18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer by Aruz Mesci, Elham Ahmadi, Amr Ali, Mohammad Gouran-Savadkoohi, Evangelia Evelyn Tsakiridis, Olga-Demetra Biziotis, Tom Chow, Anil Kapoor, Monalisa Sur, Gregory R. Steinberg, Stanley Liu, Katherine Zukotynski, Theodoros Tsakiridis

Get full text

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy by Amr Ali, Bassem Mekhaeil, Olga-Demetra Biziotis, Evangelia E. Tsakiridis, Elham Ahmadi, Jianhan Wu, Simon Wang, Kanwaldeep Singh, Gabe Menjolian, Thomas Farrell, Aruz Mesci, Stanley Liu, Tobias Berg, Jonathan L. Bramson, Gregory R. Steinberg, Theodoros Tsakiridis

Get full text

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α by Olga‐Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, Elham Ahmadi, Jianhan Wu, Simon Wang, Bassem Mekhaeil, Kanwaldeep Singh, Gabe Menjolian, Thomas Farrell, Bassam Abdulkarim, Ranjan K. Sur, Aruz Mesci, Peter Ellis, Tobias Berg, Jonathan L Bramson, Paola Muti, Gregory R Steinberg, Theodoros Tsakiridis

Get full text

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy by Fiorella Di Pastena, Gregory Pond, Evangelia E. Tsakiridis, Andre Gouveia, Elham Ahmadi, Olga-Demetra Biziotis, Amr Ali, Anand Swaminath, Gordon Okawara, Peter M. Ellis, Bassam Abdulkarim, Naseer Ahmed, Andrew Robinson, Wilson Roa, Mario Valdes, Peter Kavsak, Marcin Wierzbicki, James Wright, Gregory Steinberg, Theodoros Tsakiridis

Get full text